基于出现频率评估的肿瘤浸润淋巴细胞在雌激素受体阳性乳腺癌中的预后价值
研究利用多光子显微镜无标记获取564例乳腺癌患者TIL图像,按TIL与肿瘤细胞及胶原纤维相对位置重新定义TILs-1至TILs-3,基于出现频率构建TILs-score。Cox回归显示TILs-score是全队列、ER阳性亚组和ER阴性亚组的独立预后因素,更适用于ER阳性亚组;列线图模型联合TILs-score与临床因素进一步提高ER阳性亚组预测能力。
要点
- TILs-score是ER阳性乳腺癌DFS和OS的独立预后因素
- 列线图联合TILs-score与临床因素提高ER阳性亚组预测能力
- 首次利用多光子显微镜研究乳腺癌TILs预后价值
核心结论
- TILs-score是独立预后因素,对ER阳性乳腺癌显示强预后价值。
- 首次使用多光子显微镜研究乳腺癌TILs预后价值。
研究设计与样本
- 多光子显微镜无标记获取564例乳腺癌患者TIL图像。
- 按TIL与肿瘤细胞及胶原纤维相对位置重新定义TILs-1至TILs-3。
- 基于TILs-1至TILs-3出现频率构建评估方法,经岭回归分析获得每例患者TILs-score。
主要发现
- Cox比例风险回归显示TILs-score在全队列(n=564)、ER阳性亚组(n=352)和ER阴性亚组(n=212)中均为DFS和OS的独立预后因素,但更适用于ER阳性亚组。
- 列线图联合TILs-score与独立临床因素提高ER阳性亚组预测能力:训练队列5年DFS(OS)AUC从0.735(0.785)升至0.814(0.830),DFS(OS)HR从3.156(5.845)升至4.643(7.006)。
- 验证队列5年DFS(OS)AUC从0.749(0.748)升至0.804(0.830),DFS(OS)HR从3.104(3.701)升至3.729(5.132)。
临床怎么用
- TILs-score可作为ER阳性乳腺癌独立预后因素辅助风险评估。
- 列线图联合TILs-score与临床因素可提高ER阳性亚组预后预测能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We investigate the prognostic value of tumour-infiltrating lymphocytes (TILs) based on the evaluation of the present frequency in patients with breast cancer rather than that of the density proposed in previous research. METHODS: Multiphoton microscopy (MPM) was introduced to label-freely obtain TIL images from a total of 564 patients, and then TILs were redefined as TILs-1 to TILs-3 from MPM images according to the relative positions between TILs, tumour cells and collagen fibres. More seminally, a new method, which was based on the present frequency of TILs-1 to TILs-3, was presented for assessing the predictive ability of TILs, and then a tumour-infiltrating lymphocytes score (TILs-score) for each patient was obtained by ridge regression analysis. RESULTS: Data results from Cox proportional hazards regression analysis showed that the TILs-score was an independent prognostic factor for both disease-free survival (DFS) and overall survival (OS) in the complete cohort (n = 564), oestrogen receptor (ER)-positive subgroup (n = 352) and ER-negative subgroup (n = 212), but was more suitable for the ER-positive subgroup. Furthermore, the nomogram model combining the TILs-score with independent clinical factors further improved the predictive ability for the ER-positive subgroup: area under the curve (AUC) at 5-year DFS (OS) and hazard ratio (HR) for DFS (OS) in the training cohort increase from 0.735 (0.785) to 0.814 (0.830) and from 3.156 (5.845) to 4.643 (7.006), respectively, and in the validation cohort from 0.749 (0.748) to 0.804 (0.830) and from 3.104 (3.701) to 3.729 (5.132), respectively. CONCLUSION: The TILs-score is an independent prognostic factor and displays a strong prognostic value for ER-positive breast cancer. To our knowledge, this is the first time to use MPM for studying the prognostic value of TILs in breast cancer.
引用
- He J, Fu F, Wang W, et al. Prognostic value of tumour-infiltrating lymphocytes based on the evaluation of frequency in patients with oestrogen receptor-positive breast cancer. Eur J Cancer. 2021. PMID: 34293665. doi:10.1016/j.ejca.2021.06.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。